LacTEST 0
Sponsors
Venter Pharma S.L.
Conditions
HypolactasiaLactose intolerancePatients with celiac disease
Phase 1
Phase 4
Post-authorization phase IV low-intervention study to evaluate the efficacy under real-world conditions of the use of LacTEST 0.45 g for the diagnosis of hypolactasia in children aged 5 to 11 years presenting symptoms of lactose intolerance.
RecruitingCTIS2025-521294-13-00
Start: 2025-07-14Target: 164Updated: 2026-01-12
Clinical trial to evaluate the correlation between variation in intestinal lactase activity measured with LacTEST 0.45g and alteration of intestinal barrier integrity and/or intestinal permeability in patients with celiac disease
Not yet recruitingCTIS2026-525518-70-00
Target: 42Updated: 2026-06-11